ESPERITE launches its oncology genetic tests with SERENITY; the risk-free, convenient, and accurate test that screens the entire coding regions of the BRCA1 and BRCA2 genes, detecting all variants and ...
SERENITY, early detection of genetic predisposition to breast and ovarian cancer, widely accessible in Europe by May`s end Geneva, Switzerland - 14 April 2015 ESPERITE launches its oncology genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results